Skip to main content
Premium Trial:

Request an Annual Quote

Another Chance to Chew the Fat Over Personalized Medicine

Bernard Lo, director of the Program in Medical Ethics at UCSF, has penned a piece pushing for the next federal administration to establish a National Bioethics Advisory Council. Now is the time to consider it, since the charter for the current Council on Bioethics expires next year and the incoming president will have the opportunity to form a new advisory body. "The new Council can identify policy options, explain their pros and cons, and make recommendations to policymakers," Lo writes at Science Progress, and one area that will require really solid advice is that of personalized medicine, including direct-to-consumer genetic testing.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.